75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Equity Method Investment link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Loan with First Citizens Bank (formerly with Silicon Valley Bank) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Einstein License Agreement link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Collaboration Revenue link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Warrants (Table) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Collaboration Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Organization and Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Summary of Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Fair Value - Schedule of Fair Value Assets Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Fair Value - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Marketable Securities - Schedule of Fair Value of Available-for-Sale Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Property and Equipment, Net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Property and Equipment, Net - Summary of Depriciation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Loan with First Citizens Bank (formerly with Silicon Valley Bank) - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Loan with First Citizens Bank (formerly with Silicon Valley Bank) - Summary of Future Principal Debt Payments on Term Loan Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Loan with First Citizens Bank (formerly with Silicon Valley Bank) - Summary of Future Principal Debt Payments on Term Loan Agreement (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Equity Method Investment (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Einstein License Agreement (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Stock Based Compensation - Schedule of Estimated Fair Value of Each Stock Option Award (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Stock Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Stock Based Compensation - Schedule of Stock-Based Compensation Included in Statement of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Warrants - Schedule of Number of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Collaboration Revenue - Schedule of Collaboration revenue (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Collaboration Revenue - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Collaboration Revenue - Additional Information (Details1) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Collaboration Revenue - Additional Information (Details1) [Default] link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Leases - Schedule of Future Minimum Lease Payments on Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Leases - Schedule of Future Minimum Lease Payments on Operating Leases (Details) 3 link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Leases - Schedule of Future Minimum Lease Payments on Operating Leases (Details) 2 link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Leases - Schedule of Other Information of Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Subsequent Events (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Accrued Employee Benefits, Current Employee and board compensation Investment, Issuer Name [Axis] Trademark Trademark Policy [Text Block] Trademark. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred Stock, Shares Issued, Total Preferred stock, shares issued Preferred Stock, Shares Issued Balance Sheet Location Statement of Financial Position Location, Balance [Domain] Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosures of non-cash investing and financing activities: Long-Term Debt, Excluding Current Maturities Long-term debt, net Less: Unamortized debt issuance costs Long-term debt, net Plan Name Plan Name [Axis] Entity Current Reporting Status Entity Current Reporting Status Operating Expenses [Abstract] Operating expenses: Level 2 Fair Value, Inputs, Level 2 [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Operating Leases Rent Expenses Net Operating Leases Rent Expenses Net Rent expense Common stock, shares authorized Common Stock, Shares Authorized Cambridge, Massachusetts MASSACHUSETTS Percentage Increase in Lease Agreement Amount Percentage Increase in Lease Agreement Amount Percentage Increase in Lease Agreement Amount Document Fiscal Period Focus Document Fiscal Period Focus Dividend Yeild Long-Duration Contracts, Assumptions by Product and Guarantee, Estimated Average Investment Yield Tranche 2 [Member] Tranche 2 [Member] Tranche 2 Revenue from Contract with Customer [Abstract] Entity Shell Company Entity Shell Company Prepayment premium rate Prepayment premium rate Prepayment premium rate Aggregate amount of additional milestone payments Aggregate Amount Of Additional Milestone Payments Maximum Aggregate amount of a one-time additional milestone payments based on cumulative sales of all licensed products, maximum. Payment for Other Operating Activity Payment for License Agreement Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalent Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate Research and Development Arrangement, Contract to Perform for Others, Type [Axis] License monthly rental rate License monthly rental rate License monthly rental rate Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Common stock shares issued Pre-Funded Warrants [Member] Pre-Funded Warrants [Member] Pre-Funded Warrants Statement [Table] Statement [Table] Upfront payment Upfront Payment Upfront Payment Restricted cash Restricted Cash, Noncurrent Term Loan Agreement Member Term Loan Agreement [Member] Term Loan Agreement Deposits Increase Decrease In Deposit Liabilities Increase decrease in deposit liabilities. Noninterest Expense Commission Expense Commissions and offering expenses Proceeds from sale of common stock Proceeds From Sale Of Common Stock Net Commission Paid1 ProceedsFromSaleOfCommonStockNetCommissionPaid. Statement [Line Items] Statement [Line Items] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Expired Warrant [Member] 2024 Warrants [Member] Warrants Entity Filer Category Entity Filer Category Debt Issuance Costs, Gross, Current Less: unamortized debt issuance costs Less: unamortized debt issuance costs Total liabilities and stockholders' equity Liabilities and Equity Long-Term Debt, Current Maturities, Total Long-Term Debt, Current Maturities Current portion of long-term debt Weighed Average Exercise Price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighed Average Exercise Price, Exercisable Restructuring Type [Axis] Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Severance Costs Cash Severance Payment Operating Lease Agreement For Additional Laboratory Space Operating Lease Agreement For Additional Laboratory Space [Member] Operating lease agreement for additional laboratory space. Adjustment Related To Right Of Use Asset Adjustment related to right of use asset Adjustment related to right of use asset Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Shares Issued, Price Per Share Offering price of shares Offering price Subsequent Event [Line Items] Subsequent Event [Line Items] Two Thousand Twenty Four Common Stock Warrants [Member] Two Thousand Twenty Four Common Stock Warrants [Member] 2024 Common Stock Warrants Boston, Massachusetts Boston [Member] Boston [Member] Full time employe salary payable in first research term Full Time Employe Salary Payable in First Research Term Full time employe salary payable in first research term Collaboration and License Agreement [Member] Collaboration and License Agreement [Member] Collaboration and License Agreement Geographical Geographical [Domain] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Securities Financing Transaction Securities Financing Transaction [Axis] Prepaid Expense and Other Assets, Noncurrent Prepaid expense and other assets non current Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional paid in capital Additional Paid in Capital, Common Stock Debt Issuance Costs, Net, Total Debt Issuance Costs, Net Debt issuance costs Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, Amount Issuance of common stock, warrants and pre-funded warrants, net of issuance costs amount. Issuance of Common Stock Warrants and Pre Funded Warrants Net Of Issuance Costs Amount Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Vesting [Domain] Number of Shares, Granted Number of shares, granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Collaboration and License Agreement with ImmunoScape Pte. Ltd [Member] Collaboration and License Agreement with ImmunoScape Pte Ltd [Member] Collaboration and License Agreement with ImmunoScape Pte Ltd [Member] Laboratory Equipment Laboratory Equipment [Member] Laboratory equipment. Net loss per common share, basic Earnings Per Share, Basic, Total Earnings Per Share, Basic Summary of depreciation expense. Summary Of Depreciation Expense Table [Text Block] Summary of Depreciation Expense Number of Shares, Outstanding Beginning Balance Number of Shares, Outstanding Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Debt Issuance Costs Debt, Policy [Policy Text Block] Interest income Interest Income (Expense), Nonoperating Total current liabilities Liabilities, Current Marketable securities, Maturity period Debt Securities, Held-to-Maturity, Threshold Period Past Due Account receivable Increase (Decrease) in Accounts Receivable Adjustments to reconcile net loss to cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Issuance of common stock from ATM offering, net of sales agent commission and fees, Shares Issuance of common stock from ATM offering, net of sales agent commission and fees, Shares Issuance of common stock from ATM offering, net of sales agent commissions and fees, Shares OneTimeUpFrontPaymentPayableAsConsiderationRDActivities One Time Up Front Payment Payable As Consideration RD Activities One time up front payment payable as consideration RD activities February Fifteen Two Thousand Twenty Four [Member] February Fifteen Two Thousand Twenty Four [Member] February 15, 2024 Sales Agreement November 2019 Agreement2 [Member] Agreement 2 member. Transaction Expense Transaction Expense [Member] Transaction expense. Total Receive Upfront Payments Total Receive Upfront Payments Total receive upfront payments Accounting Standards Update Accounting Standards Update [Axis] Long-Duration Contracts, Assumptions by Product and Guarantee, Risk-Free Rate Long-Duration Contracts, Assumptions by Product and Guarantee, Risk-Free Rate Risk-Free Rate Equity, Attributable to Parent [Abstract] Stockholders' equity: Entity Small Business Entity Small Business Reverse Stock Split1 [Policy Text Block] Reverse Stock Split1 [Policy Text Block] Reverse Stock Split Increase (Decrease) in Accrued Liabilities, Total Accrued expenses Increase (Decrease) in Accrued Liabilities Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Value Added Tax Receivable, Current Foreign withholding tax receivable First Amendment First Amendment [Member] First Amendment ASU 2016-02 Accounting Standards Update 2016-02 [Member] Accretion Expense Accretion expenses Additional Common Stock Warrant Purchases Common Shares Additional Common Stock Warrant Purchases Common Shares Additional common stock warrant purchases common shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of Shares, Forfeited Einstein license agreement. Einstein License Agreement [Member] Einstein License Agreement Proceeds from Issuance Initial Public Offering Proceeds from Issuance Initial Public Offering Offering price Sale of Stock, Price Per Share Type of Cost, Good or Service [Extensible List] Cost, Product and Service [Extensible Enumeration] COVID 19 Pandemic Covid19 Pandemic Policy [Text Block] Disclosure of accounting policy for Covid 19 pandemic. Organization, Consolidation and Presentation of Financial Statements [Abstract] Proceeds from sale of common stock Proceeds From Sale Of Common Stock Proceeds From Sale Of Common Stock Net Commission Paid Proceeds from sale of common stock net commission paid. Lease Contractual Term Lease Contractual Term [Axis] Leases [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures [Abstract] ImmunoScape Pte Ltd [Member] ImmunoScape Pte Ltd ImmunoScape Pte Ltd [Member] Lessee Lease Description [Line Items] Lessee, Lease, Description [Line Items] Amendment Flag Amendment Flag lump sum Payment lump sum Payment Class of Warrant or Right, Number of Securities Called by Warrants or Rights Non-cash interest expense to the lease liability Finance Lease, Interest Expense Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Oppenheimer & Co. Inc. [Member] Oppenheimer & Co. Inc. [Member] Oppenheimer & Co. Inc. [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Additional Milestone Payments Additional Milestone Payments Common Stock [Member] Common Stock Long-Term Debt, Maturity, Year One 2024 Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Lessee, Operating Lease, Liability, to be Paid, Year Three 2028 Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Schedule Of Available For Sale Securities [Line Items] Debt Securities, Available-for-Sale [Line Items] Share based compensation arrangement by share based payment award fair value of options exercisable intrinsic fair value per share. Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share Intrinsic value of exercisable fair value per share Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Schedule of Estimated Fair Value of Each Stock Option Award Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Level 2 Fair Value Hierarchy and NAV [Axis] Supplemental Cash Flow Information [Abstract] License monthly rental rate second year License monthly rental rate second year License monthly rental rate second year Current Liabilities Current Liabilities [Member] Current liabilities. Balance Sheet Location Statement of Financial Position Location, Balance [Axis] Warrants Issued December 2025 Warrants Issued December Two Thousand Twenty Five [Member] Warrants Issued December Two Thousand Twenty Five [Member] Payments for Underwriting Expense Commissions and offering expenses Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Approximately Received of Upfront Payments Approximately Received of Upfront Payments Approximately Received of Upfront Payments Document Type Document Type Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Equity, Fair Value Disclosure Equity, Fair Value Disclosure, Total Fair value of equity interest Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Entity Central Index Key Line of Credit Facility [Table] Investments, Debt and Equity Securities [Abstract] WSJ Prime Rate plus Prime Rate [Member] Summary of Estimated Useful Lives of Assets Estimated Useful Lives Of Assets Table [Text Block] Estimated useful lives of assets. Valuation Approach and Technique [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net decrease in cash, cash equivalents, and restricted cash Subsequent Event Type [Domain] Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount LG Chem Life Sciences. LG Chem Life Sciences L G Chem Life Sciences [Member] Common stock, par value Common Stock, Par or Stated Value Per Share Accounting Standards Update Accounting Standards Update [Domain] Security Deposit Security Deposit Common Stock Warrants to purchase Proceeds from Issuance of Warrants Share-Based Payment Arrangement, Tranche One [Member] Tranche A Silicon Valley Bank [Member] Silicon Valley Bank [Member] Silicon Valley Bank Stock based payment options outstanding weighted average remaining term Weighted Average Remaining Contractual Life (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Marketable securities of investments Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Debt Securities, Available-for-Sale, Total Debt Securities, Available-for-Sale Marketable securities Gain (Loss) on Termination of Lease (Gain) on lease termination (Gain) on lease termination Debt Instruments [Abstract] Number of Shares, Exercised Exercise of stock options, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Disclosure [Abstract] Milestone payments received Milestone Payments Received Milestone payments received. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary of significant accounting policies. Total Accrued expenses Accrued Liabilities, Current Total Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Sublicensing Revenues Received Percentage Sublicensing Revenues Received Percentage Sublicensing revenues received percentage Placement Fees Placement Fees Placement fees Document Quarterly Report Document Quarterly Report Restricted Cash and Cash Equivalents Restricted Cash and Cash Equivalents [Axis] Increase Decrease In Other Payable Increase Decrease In Other Payable Other payable Lab Space Lease Member Lab Space Lease [Member] Lab Space Lease Member Additional laboratory lease third amendment member. Additional Laboratory Lease Third Amendment [Member] Additional Laboratory Lease Third Amendment Einstein Einstein [Member] Einstein. Entity Address State or Province Entity Address, State or Province Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, Share Issuance of common stock, warrants and pre-funded warrants, net of issuance costs Issuance of Common Stock Warrants and Pre Funded Warrants Net of Issuance Costs Lessee operating lease monthly rental payments for remaining term Lessee Operating Lease Monthly Rental Payments For Remaining Term Lessee operating lease monthly rental payments for remaining term. Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Percentage of right to development and commercialized Percentage of right to development and commercialized Percentage of right to development and commercialized Two Thousand Twenty Five Common Stock Warrants [Member] Two Thousand Twenty Five Common Stock Warrants [Member] 2025 Common Stock Warrants Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Geographical Geographical [Axis] Line of Credit Facility, Lender [Domain] Warrants Issued April Two Thousand Twenty Five [Member] Warrants Issued April Two Thousand Twenty Five [Member] Warrants Issued April 2025 Milestone payment associated with contract liability Contract with Customer, Liability, Revenue Recognized Jefferies LLC Jefferies LLC [Member] Warrants Warrants [Text Block] Warrants. Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses Einstein License Agreement Collaborative Arrangement Disclosure [Text Block] Stock Option Equity Option [Member] Lessee operating lease monthly rental payments Lessee Operating Lease Monthly Rental Payments Amount of cash outflow of lessee operating lease monthly rental payments. Eligible to earn achievement of certain research and development milestones Eligible To Earn Achievement Of Certain Research And Development Milestones Eligible to earn achievement of certain research and development milestones. Subsequent Event [Member] Subsequent Event Net of accumulated amortization Capitalized Contract Cost, Accumulated Amortization Marketable Securities, Policy [Policy Text Block] Marketable Securities Property, Plant and Equipment [Abstract] Nonrefundable milestone payments. Nonrefundable Milestone Payments Nonrefundable milestone payments Other Assets, Noncurrent, Total Other long-term assets Other long-term assets Other Assets, Noncurrent Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Less: unamortized debt issuance costs Debt Securities, Available-for-sale, Current, Total Marketable securities Debt Securities, Available-for-Sale, Current Proceeds from sale of common stock Receive upfront payments Receive Upfront Payments Receive Upfront Payments Antidilutive Securities Antidilutive Securities [Axis] Warrant, Exercise Price, Decrease Exercise price Number of Shares, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Milestone payment upon the renewal Milestone Payment Upon the Renewal Milestone payment upon the renewal Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of Stock-Based Compensation Included in Statement of Operations and Comprehensive Loss Related Party Transaction Related Party Transaction [Axis] AOCI Attributable to Parent AOCI Attributable to Parent [Member] Investment, Issuer Name [Domain] Debt Instrument, Interest Rate, Basis for Effective Rate Interest rate Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Achievement of certain commercial milestones Achievement Of Ccertain Commercial Milestones Achievement of certain commercial milestones. Lessee, Operating Lease, Option to Extend Extension of lease term Warrants Issued November 2022 Warrants Issued November Two Thousand Twenty Two [Member] Warrants Issued November Two Thousand Twenty Two [Member] Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Preferred stock, $0.001 par value; 10,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2026 and December 31, 2025 Fair value of option Share based compensation arrangement by share based payment award fair value of options at market close price. Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Market Close Price Minimum Minimum [Member] Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value per share Financial Instrument Financial Instrument [Axis] Current assets: Assets, Current [Abstract] Interest expense Interest Expense, Other Public Offering Policy [Text Block] Disclosure of accounting policy for public offering. Public Offerings Amortization of Intangible Assets, Total Amortization of intangible assets Amortization of Intangible Assets Milestone Fees Milestone Fees Level 3 Fair Value, Inputs, Level 3 [Member] Schedule of Fair Value Assets Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Unrealized gain on investments Unrealized Gain (Loss) on Investments Long-term research and development contract liability Research and development contract liability, net of current portion Research And Development Contract Liability Noncurrent Research and development contract liability, noncurrent. Current liabilities: Liabilities, Current [Abstract] Additional Laboratory Lease Fourth Amendment [Member] Additional Laboratory Lease Fourth Amendment [Member] Balance, Shares Balance, Shares Shares, Outstanding Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Cash obligation percentage Cash obligation percentage Cash obligation percentage Commitments and Contingencies Commitments and contingencies (Note 12) Leases Lessee, Leases [Policy Text Block] Cash Concentrations Cash Concentration Policy [Text Block] Cash Concentration Policy [Policy Text Block] Shareholders' Equity and Share-Based Payments [Text Block] Stock-based compensation Other Short-Term Borrowings Other short-term debt General and Administrative Expense [Member] General and Administrative Present value of lease payments Operating Lease, Liability Total Operating lease, liability Debt Instrument, Basis Spread on Variable Rate Variable interest rate (percentage) Short-term Debt, Total Term loan Short-term debt, net Short-term debt Time to Liquidity Event Time to Liquidity Event Time to liquidity event Long-Term Debt, Maturity, Year Two 2025 Lessee Lease Description [Table] Lessee, Lease, Description [Table] Interest Income (Expense), Operating Interest Income (Expense), Net, Total Interest expense Net Loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Lease Contractual Term Lease Contractual Term [Domain] Other current payable Other Loans Payable, Current Up Front Non Refundable Payment Up front non refundable payment. Up Front Non Refundable Payment Long-Term Debt, Type [Domain] Weighted average common shares outstanding, basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Intrinsic value of exercisable stock options TwoThousandTwentyFivePre-FundedWarrantsMember TwoThousandTwentyFivePre-FundedWarrantsMember 2025 Pre-Funded Warrant Milestone payments for each new indication of licensed product Aggregate Amount Of Milestone Payments For Each New Indication Of Licensed Product Maximum Aggregate amount of milestone payments for each new indication of licensed product, maximum. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] 2016 Omnibus Incentive Plan Two Thousand Sixteen Omnibus Incentive Plan [Member] Two thousand sixteen omnibus incentive plan. Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Two Thousand Twenty Five Underwriting Agreement [Member] Two Thousand Twenty Five Underwriting Agreement [Member] 2025 Underwriting Agreement [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Stock options granted purchase shares Equity investment for research collaboration agreement Equity Investment For Research Collaboration Agreement Equity investment for research collaboration agreement. Proceeds from issuance of private placement of pre-funded warrants and common stock warrants Proceeds from Issuance of Private Placement Subsequent Events Subsequent Events [Text Block] Long-Term Debt Long-term debt, net of current portion, unamortized debt issuance costs Current portion of long-term debt, net Long-term debt APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Variable Rate [Domain] Total stockholders' equity Balance Balance Equity, Attributable to Parent Merck Merck [Member] Merck. Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Company Paid Collaboration And License Agreements Fees Company Paid Collaboration And License Agreements Fees Increase in security deposit Increase in security deposit Increase in security deposit Statement of Stockholders' Equity [Abstract] Share-Based Payment Arrangement, Tranche Two [Member] Tranche B Type of Restructuring [Domain] Valuation Approach and Technique [Domain] Use of Estimates Use of Estimates, Policy [Policy Text Block] Equity Method Investment [Table] Leasehold Improvements Leasehold Improvements [Member] Fair Value Fair Value Disclosures [Text Block] Tranche B loan [Member] Tranche B loan [Member] Tranche B loan Offering expenses Offering expenses Offering expenses Warrants and Rights Note Disclosure [Abstract] Schedule of Accrued Liabilities [Table Text Block] Summary of Accrued Expenses Prepaid Expense and Other Assets Prepaid expenses and other short-term assets In Process Research and Development [Member] In Process Research and Development Plan Name Plan Name [Domain] Interest Expense, Operating and Nonoperating Interest Expense, Total Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Percenatage of equity issued and outstanding Equity Method Investment, Ownership Percentage Licensing Fees and Costs Licensing Fees And Costs Policy [Text Block] Licensing fees and costs. Cost of Product and Service Sold Cost of Goods and Services Sold, Total Patent expenses Cost of Product and Service Sold 2022 Pre-Funded Warrants Two Thousand Twenty Two Pre-Funded Warrants [Member] Two Thousand Twenty Two Pre-Funded Warrants [Member] Organization and Basis of Presentation Business Description and Basis of Presentation [Text Block] Certificate of Deposit Certificates of Deposit [Member] Accrued contract manufacturing services current. Accrued Contract Manufacturing Services Current Contract manufacturing services Shares remaining to be issued as of September 30, 2023 Shares remaining to be issued as of December 31, 2022 Class of Warrant or Right, Outstanding Purchase of shares Outstanding common stock warrants at March 31, 2026 Milestone Payment Milestone Payment Milestone payment Related and Nonrelated Parties [Axis] Class Of Warrant Or Right [Table] Class of Warrant or Right [Table] Einstein License License Agreement For Patent Rights [Member] License agreement for patent rights. Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Agreed To Increase Full Time Employee Salaries Agreed To Increase Full Time Employee Salaries Agreed to Increase full time employee salaries Entity Address, City or Town Entity Address, City or Town February Fifteen Two Thousand Twenty Three [Member] February Fifteen Two Thousand Twenty Three [Member] February 15, 2023 Security Exchange Name Security Exchange Name Long-Term Debt, Gross Total principal payments Total Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross Total property and equipment Collaboration and License Agreement Description Collaboration and License Agreement Description Counterparty Name Counterparty Name [Axis] Tranche A loan [Member] Tranche A loan [Member] Tranche A loan Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value weighted average grant date fair value Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Investment Owned, Cost Carrying value of the investment Common stock warrant purchases common shares Common stock warrant purchases common shares Common stock warrant purchases common shares Interest Paid, Excluding Capitalized Interest, Operating Activity Cash paid for interest Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement Statistical Measurement [Domain] Exercise price of common stock warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted average exercise price of common stock warrants at March 31, 2026 Total current assets Assets, Current Current assets Stock-based compensation Share-Based Payment Arrangement, Expense 2024 Pre-funded warrants [Member] Two Thousand Twenty Four Pre Funded Warrants [Member] Two thousand twenty four pre funded warrants. Document Period End Date Document Period End Date Equity Method Investments and Joint Ventures [Abstract] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Unrealized gain from available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Additional amount receivable research development regulatory and sales milestones Additional Amount Receivable Research Development Regulatory And Sales Milestones Additional amount receivable research development regulatory and sales milestones. Number of Shares, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Five Pre-Funded Warrants [Member] Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Five Pre-Funded Warrants [Member] 2025 Common Stock Warrants and 2024 Pre-Funded Warrants Schedule Of Common Stock Warrants Activity Table Text Block. Summary of Common Stock Warrant Activity Schedule Of Common Stock Warrants Activity Table [Text Block] Gain (Loss) on Disposition of Property Plant Equipment, Total Gain (Loss) on disposal of property and equipment Gain (Loss) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Loss (gain) on fixed asset disposal Loss (gain) on sale of property and equipment Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Weighted average contractual life Statement of Financial Position [Abstract] Revenue Recognition Revenue [Policy Text Block] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] License agreement entered date. License Agreement Entered Date License agreement entered date Additional Laboratory Lease Second Amendment [Member] Additional Laboratory Lease Second Amendment [Member] Additional Laboratory Lease Second Amendment Variable Interest Entities policy Variable Interest Entities policy Variable Interest Entities Collaboration Revenue Recognized at a Point in Time Collaboration Revenue Recognized at a Point in Time Revenue recognized at a point in time Total liabilities Liabilities Contract liabilities. Contract Liabilities Contract Liabilities [Member] Financial Instruments Financial Instruments [Domain] Valuation Technique, Option Pricing Model [Member] Valuation Technique, Option Pricing Model [Member] Equity Method Investments [Policy Text Block] Equity Method Accounting Entertainment, License Agreement for Program Material, Capitalized Cost Capitalized license expenses Lessee, Operating Lease, Liability, to be Paid, Year Two 2027 Recognized Gain Recognized Gain Recognized Gain ATM Sales Agreement [Member] ATM Sales Agreement [Member] ATM Sales Agreement Variable Rate [Axis] Indefinite-lived Intangible Assets, Major Class Name Indefinite-Lived Intangible Assets, Major Class Name [Domain] Received Equity Percentage Received Equity Percentage Received equity percentage Equity investment nonrefundable upfront cash payment Equity Investment Nonrefundable Upfront Cash Payment Equity investment nonrefundable upfront cash payment. Weighted average common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Entity File Number Securities Act File Number Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary of significant accounting policies. Cover [Abstract] Achievement of certain research and development milestones Achievement Of Certain Research And Development Milestones Achievement of certain research and development milestones. Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Exercise Price of Pre-Funded Warrant Exercise Price of Pre-Funded Warrant Exercise Price of Pre-Fund warrant Prepaid expenses and other short-term assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Threshold Amount Threshold Amount Threshold Amount US Treasury Securities [Member] U.S. Treasury securities Sale of Stock [Domain] General and Administrative Expense, Total General and administrative General and Administrative Expense Research and development contract liability Increase Decrease In Research And Development Contract Liability Increase (decrease) in research and development contract liability. Fair value assets transfers between Level 2 and Level 3 Fair Value Assets Among Level2 And Level3 Transfers Amount Fair value assets among level 2 and level 3 transfers amount. Subsequent Event [Table] Subsequent Event [Table] Adjustments to Additional Paid in Capital, Warrant Issued Additional Paid In Capital Warrant Issued Deposits, current portion Deposits Assets, Current Short-term research and development contract liability Research And Development Contract Liability Current Research and development contract liability, current. Research and development contract liability, current portion Estimated useful lives Property, Plant and Equipment, Useful Life New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Not Yet Adopted Schedule of Future Minimum Lease Payments for Operating Lease Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Gain (Loss) on Disposition of Assets, Total Gain (Loss) on Disposition of Assets Loss (gain) on sale of property and equipment (Gain) on lease termination Employee Severance [Member] Employee Severance Common stock conversation description Debt Instrument, Redemption, Description Ono Collaboration and Option Agreement [Member] Ono Collaboration and Option Agreement [Member] Ono Collaboration and Option Agreement Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Depreciation total Depreciation, Total Depreciation expense Depreciation Debt Instrument, Convertible, Stock Price Trigger Common stock minimum bid price Accrued contract research services current. Accrued Contract Research Services Current Contract research services Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Operating lease liability, current portion Operating Lease, Liability, Current Operating lease liabilities, current Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Transaction price recorded in liabilities Revenue, Remaining Performance Obligation, Amount Document Transition Report Document Transition Report Total operating expenses Operating Expenses Accrued Liabilities, Current [Abstract] Research and Development Expense, Total Research and development Research and Development Expense Recognized Revenue Cost of Revenue Cost of Revenue, Total Leases Lessee, Operating Leases [Text Block] Statement of Cash Flows [Abstract] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Computer Equipment Computer and office equipment [Member] Computer Equipment [Member] Net loss Net loss Percenatage of equity issued and outstanding Received Issued And Outstanding Equity Percentage Received Issued And Outstanding Equity Percentage Common stock warrants life Warrants and Rights Outstanding, Term Weighted average contract remaining life (in years) at March 31, 2026 Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Two Thousand Twenty Four Pre-Funded Warrants [Member] Two Thousand Twenty Four Pre-Funded Warrants [Member] 2024 Pre-Funded Warrants Assets Assets [Abstract] Fair Value Assets Among Level1 AndLevel2 Transfers Amount Fair Value Assets Among Level1 AndLevel2 Transfers Amount Fair value assets transfers between Level 1 and Level 2 Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Final payment of debt Repayments of Debt Operating lease liability Increase Decrease In Operating Lease Liabilities Increase decrease in operating lease liabilities. Document Fiscal Year Focus Document Fiscal Year Focus Fair Value Debt Securities, Trading and Available-for-Sale Debt Securities, Trading and Available-for-Sale, Total Revenue expected to be recognized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Office space for lease Land Subject to Ground Leases Research and Development Research and Development Expense [Member] Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Technology Transfer Payments Technology Transfer Payments Technology transfer payments Change In Operating Lease Right Of Use Asset Change in operating lease right-of-use asset. Decrease in the carrying amount of right-of-use-assets Repayment of term loans Payment of term loan Payment of term loan Cash collected from sale of fixed assets Property, Plant and Equipment, Disposals Disposals of property and equipment First Research Term Processed Milestone Payment Under Agreement First Research Term Processed Milestone Payment Under Agreement First Research Term Processed Milestone Payment Under Agreement Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year One 2026 (remaining 9 months) Accretion of final payment on term loans Accretion of final payment on term loan Accretion of final payment on term loan Public Offering [Member] Public Offering [Member] Public Offering Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Four Pre-Funded Warrants [Member] Two Thousand Twenty Four Common Stock Warrants And Two Thousand Twenty Four Pre-Funded Warrants [Member] 2024 Common Stock Warrants and 2024 Pre-Funded Warrants Derivative Instrument Derivative Instrument [Axis] Share-Based Payment Arrangement [Abstract] Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized stock-based compensation Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Assets, Fair Value Disclosure Cash equivalents Cash equivalents and marketable securities Sale of Stock [Axis] Success-based Research, Development and Commercial Milestone Payments Success-based Research, Development and Commercial Milestone Payments Success-based research, development and commercial milestone payments Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Equity Method Investments and Joint Ventures Disclosure [Text Block] Equity Method Investment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Private Placement Private Placement [Member] Common Stock Options Common Stock Options [Member] Common stock options. Issuance of common stock from ATM offering, net of sales agent commission and fees, Amount Issuance of common stock from ATM offering, net of sales agent commission and fees, Amount Issuance of common stock from ATM offering, net of sales agent commissions and fees, Amount Title of 12(b) Security Title of 12(b) Security License Agreement [Member] License Agreement [Member] License Agreement Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited Related and Nonrelated Parties [Domain] Proceed From Pre Funded Warrants Financing Proceed From Pre Funded Warrants Financing Proceed From Pre Funded Warrants Financing Disposal of property and equipment, gross Property Plant And Equipment Disposal Gross Property plant and equipment disposal gross. Collaborative Arrangement and Arrangement Other than Collaborative [Table] Shares Acquired, Weighted Average Discount to Net Assets, Percentage Percent of ordinary shares Class Of Warrant Or Right [Line Items] Class of Warrant or Right [Line Items] Albert Einstein College Of Medicine Albert Einstein College Of Medicine [Member] Albert Einstein College of Medicine. Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Summary of Property and Equipment Property, Plant and Equipment [Table Text Block] Weighted Average Exercise Price, Outstanding Beginning Balance Weighted Average Exercise Price, Outstanding Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Warrants Issued September Two Thousand Twenty Four [Member] Warrants Issued September Two Thousand Twenty Four [Member] Warrants Issued September 2024 Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Additional Paid-in Capital [Member] Additional Paid-in Capital Collaboration Agreement with Merck Collaboration Agreement With Merck [Member] Collaboration agreement with merck. HC Wainwright & Co LLC [Member] HC Wainwright & Co LLC [Member] HC Wainwright & Co LLC [Member] Measurement Frequency Measurement Frequency [Domain] Income Statement Location Statement of Income Location, Balance [Axis] Trading Symbol Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Security deposit Security Deposit Liability Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Subsequent Event Type [Axis] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Fair Value Measurements, Recurring Basis Fair Value, Recurring [Member] Entity Ex Transition Period Entity Ex Transition Period Schedule of Equity Method Investments [Line Items] Total lease payments Lessee, Operating Lease, Liability, to be Paid Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Development and commercial milestone payment payable cuo biopharma Development and commercial milestone payment payable cuo biopharma Development and commercial milestone payment payable cuo biopharma Development and Regulatory Milestone Payments Development and Regulatory Milestone Payments Development and regulatory milestone payments ImmunoScape Collaboration and License Agreement ImmunoScape Collaboration and License Agreement [Member] ImmunoScape Collaboration and License Agreement [Member] Equity Components Equity Components [Axis] Adjustment related to lease liability Adjustment Related To Lease Liability Adjustment related to lease liability Milestone payments for each product, process or service Aggregate Amount Of Milestone Payments For Each Product Process Or Service Maximum The maximum aggregate amount of milestone payments for each product, process or service. Schedule of Collaboration Revenue [Table TextBlock] Schedule of Collaboration Revenue [Table TextBlock] Schedule of Collaboration revenue Total other income, net Total other income Nonoperating Income (Expense) Equity Component Equity Component [Domain] Option Time Based Payment Option Time Based Payment Option time based payment Schedule of Future Minimum Lease Payments for Operating Lease Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] License monthly rental rate third year License monthly rental rate third year License monthly rental rate third year Additional time based payment Additional Time Based Payment Additional Time Based Payment On November Sixteen Two Thousand Twenty Two [Member] On November Sixteen Two Thousand Twenty Two [Member] On November 16, 2022 [Member] Common Stock Warrants [Member] Common Stock Warrants [Member] 2025 Common Stock Warrants February Two Thousand Twenty Five [Member] February Two Thousand Twenty Five [Member] February, 2025 Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Class Of Pre Funded Warrant Or Right Outstanding Class Of Pre Funded Warrant Or Right Outstanding Outstanding pre-funded warrants at March 31, 2026 Maximum [Member] Maximum Statistical Measurement Statistical Measurement [Axis] Weighted Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, $0.001 par value; 300,000,000 shares authorized; 3,255,359 and 3,220,707 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Other Long-Term Debt, Current Current portion of long-term debt, net Current portion of long-term debt, net Proceeds from sale of common stock. Proceeds From Sale of Common Stock Unsettled cash receivable from the sale of common stock Net proceeds Consolidation Consolidation, Policy [Policy Text Block] Laboratory Equipment Equipment [Member] Proceeds from Sale of Furniture and Fixtures Cash collected from sale of assets Debt Instrument Final Fee Debt Instrument Final Fee Final fee (percentage) Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Amortization of Debt Issuance Costs Amortization of debt issuance costs Commercial milestone payments Commercial Milestone Payments Commercial Milestone Payments Pre Funded Warrants Pre Funded Warrants Pre Funded Warrants Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies Preferred stock, shares authorized Preferred Stock, Shares Authorized Securities Financing Transaction Securities Financing Transaction [Domain] Lender Name [Axis] Accrued Liability Accounts Payable and Other Accrued Liabilities Collaboration Revenue Revenue from Contract with Customer [Text Block] Entity Registrant Name Entity Registrant Name Debt Disclosure [Text Block] Loan with First Citizens Bank (formerly with Silicon Valley Bank) Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Purchase of Additional Shares Of Common Stock Purchase of Additional Shares Of Common Stock Purchase of additional shares of common stock. Subsequent Events [Abstract] Income Tax Expense (Benefit), Total Income tax expense Income Tax Expense (Benefit) Underwriting Agreement [Member] Underwriting Agreement [Member] Underwriting Agreement Total collaboration revenue Total Collaboration Revenue Total Collaboration Revenue Measurement Frequency Measurement Frequency [Axis] Fair Value Assets Among Level2 AndLevel3 Transfer Amount Fair Value Assets Among Level2 AndLevel3 Transfer Amount Fair value assets transfers between Level 2 and Level 3 Einstein License And Service Agreement Einstein License And Service Agreement [Member] Einstein license and service agreement. Proceeds from Issuance of Common Stock Net proceeds from offering Proceeds from issuance of common stock, warrants and pre-funded warrants, net of transaction costs Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Common Stock Warrant at a combined offering price Common Stock Warrant at a combined offering price Common Stock Warrant at a combined offering price Total assets Assets Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Weighted Average Remaining Contractual Life (in Years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Statement [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Warrants purchase shares of common stock Warrants purchase shares of common stock Warrants purchase shares of common stock Sale of common stock, number of shares Sale of Stock, Number of Shares Issued in Transaction Stock Issued During Period, Shares, New Issues Issuance of common stock from public offerings, net of underwriter discounts, Shares Shares of common stock Property, Plant, and Equipment, Salvage Value Sale fully Depreciated lab Equipment Capitalized license expenses Capitalized License Expenses Capitalized License Expenses Net loss per common share, diluted Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Proceeds From At Time Market Offering Net Of Commission And Fees Proceeds from At the time market offering net of commission and fees. Proceeds from ATM offering, net of sales agent commissions and fees Cash obligation Cash Obligation Cash obligation City Area Code City Area Code Debt Instrument, Convertible, Conversion Date Closing Date Restricted Cash and Cash Equivalents, Current, Total Restricted cash used to collateralize a credit card Restricted Cash and Cash Equivalent, Current Pre-Funded Warrant Offer Price Pre-Funded Warrant Offer Price Pre-Funded Warrant Offer Price Number ff supporting technology. Number Of Supporting Technology Number of supporting technology Collaboration Agreement with LG Chem Life Sciences Collaboration Agreement With L G Chem Life Sciences [Member] Collaboration agreement with LG Chem Life Sciences. Patent Expenses Intangible Assets, Finite-Lived, Policy [Policy Text Block] Research and Development Activities Option Period Research and Development Activities Option Period Research and development activities option period Counterparty Name Counterparty Name [Domain] License monthly rental rate remainder of the term License monthly rental rate remainder of the term License monthly rental rate remainder of the term License Monthly Rental Partial Credit License Monthly Rent Partial Credit License monthly rental partial credit Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Stock split Stockholders' Equity Note, Stock Split, Conversion Ratio Investor Investor [Member] License Agreement License Agreement Terms [Member] Award Date Award Date [Axis] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net Property and equipment, net License monthly rental rate first year License monthly rental rate first year License monthly rental rate first year Collaboration Revenue Recognized Over Time Collaboration Revenue Recognized Over Time Revenue recognized over time Two Thousand Twenty Two Pre Funded Warrants [Member] Two Thousand Twenty Two Pre Funded Warrants [Member] 2022 Pre-funded warrants [Member] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Loss from operations Loss from operations Operating Income (Loss) Award Date Award Date [Domain] Additional Received Upfront Payments Additional Received Upfront Payments Stifel Nicolaus and Company Inc. Stifel Nicolaus And Company Incorporated [Member] Stifel Nicolaus And Company Incorporated Member Accumulated Deficit Retained Earnings [Member] Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Operating lease, weighted average discount rate Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Liability, Noncurrent Operating lease liability, net of current portion Operating lease liabilities, non-current On April 14, 2025 [Member] On April Fourteen Two Thousand Twenty Five [Member] On April Fourteen Two Thousand Twenty Five [Member] Level 1 Fair Value, Inputs, Level 1 [Member] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Schedule of Other Information of Operating Leases Lease, Cost [Table Text Block] Deposits Deposits Assets, Noncurrent Schedule of Number of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Nonoperating Income (Expense) [Abstract] Other income (expense): Marketable Securities [Table Text Block] Summary of marketable securities Derivative Contract Derivative Contract [Domain] Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Debt Securities Available For Sale [Table] Debt Securities, Available-for-Sale [Table] Entity Interactive Data Current Entity Interactive Data Current Income Statement Location Statement of Income Location, Balance [Domain] Other Income Other Income [Member] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Furniture and Fixtures Furniture and Fixtures [Member] Forty G office and additional laboratory. Forty G Office and Additional Laboratory [Member] 40G Office and Additional Laboratory Entity Tax Identification Number Entity Tax Identification Number Accretion of final payment Accretion of final payment Long-Term Debt, Type [Axis] Offering Expenses Placement Agent Fees And Offering Expenses Placement Agent Fees And Offering Expenses Local Phone Number Local Phone Number Related Party Transaction Related Party Transaction [Domain] Class Of Pre Funded Warrant Or Right Exercise Price Of Warrants Or Rights 1 Class Of Pre Funded Warrant Or Right Exercise Price Of Warrants Or Rights 1 Weighted average exercise price of pre-funded warrants at March 31, 2026 Monthly installments Monthly installments Monthly installments On September 26, 2024 [Member] On September Twenty Six Two Thousand Twenty Four [Member] On September Twenty Six Two Thousand Twenty Four [Member] Trademarks Trademarks [Member] Accounting Policies [Abstract] Debt Instrument, Convertible, Threshold Trading Days Common stock trading days Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] BI Collaboration and License Agreement BI Collaboration and License Agreement [Member] BI Collaboration and License Agreement [Member] Revenue from Contract with Customer, Excluding Assessed Tax, Total Collaboration revenue Revenue from Contract with Customer, Excluding Assessed Tax Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Accrued Professional Fees, Current Professional services Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets Indefinite-Lived Intangible Assets [Axis] Gain and loss on right of use asset. Gain Loss On Right Of Use Asset Loss on right-of-use asset